Vaccine Adjuvants & Delivery Technologies

A Vaccine adjuvant is an ingredient of a vaccine that helps create a stronger immune response in the patient’s body.  In other words, adjuvants help vaccines work better. Some vaccines made from weakened or dead germs contain naturally occurring adjuvants and help the body produce a strong protective immune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. These vaccines often must be made with adjuvants to ensure the body produces an immune response strong enough to protect the patient from the germ he or she is being vaccinated against. Aluminum gels or aluminum salts are vaccine ingredients that have been used in vaccines since the 1930s.  Small amounts of aluminum are added to help the body build stronger immunity against the germ in the vaccine. Aluminum is one of the most common metals found in nature and is present in air, food, and water. The amount of aluminum present in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA).

  • Next-Generation Adjuvants
  • Advances in DNA Vaccines, TLRS and Combination Adjuvants
  • Addressing Unmet Vaccine Needs
  • DNA delivery technologies
  • Needle-free vaccine delivery
  • Nanopatch Technologies
  • Adjuvants and Delivery systems for prophylactic and therapeutic vaccines

Related Conference of Vaccine Adjuvants & Delivery Technologies

August 01-02, 2024

44th Global Summit and Expo on Vaccines & Immunology

Montreal, Canada
September 09-10, 2024

4th International Conference on Vaccine Research

Madrid, Spain
September 09-10, 2024

7th International Conference on Vaccines and Immunology

Madrid, Spain
October 31-01, 2024

36th International Conference on Vaccines and Immunization

Amsterdam, Netherlands
November 28-29, 2024

6th World Congress on Vaccine and Immunology

Paris, France

Vaccine Adjuvants & Delivery Technologies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in